Jean-Louis Dasseux
President at Cerenis Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cyrille Tupin | M | 48 |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 17 years |
| Emmanuel de Fougeroux | M | - | 16 years | |
| Denis Lucquin | M | 67 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 19 years |
| Johan Rutger Christenson | M | 65 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Christian Chavy | M | 75 | 9 years | |
| Laura Coruzzi | M | 71 | 9 years | |
| Karen Noël | F | 51 | 7 years | |
| Emmanuel Huynh | M | 54 | 5 years | |
| Mary L. Campbell | F | - |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | - |
| Alexandra Goll | M | 68 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Renee Benghozi | M | - | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William F. Brinkerhoff | M | - | 6 years | |
| Catherine Moukheibir | F | 64 | 3 years | |
| Michael Davidson | M | 67 | 4 years | |
| Richard Pasternak | M | 75 | - | |
| Barbara Yanni | F | 69 | 2 years | |
| Jean-Pierre Garnier | M | 75 | - | |
| Marc Rivière | M | 65 | - | |
| Narendra D. Lalwani | M | 71 | 7 years | |
| Daniela Oniciu | M | - | 9 years | |
| Shawn Benoit | M | - | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 19 | 90.48% |
| United States | 5 | 23.81% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jean-Louis Dasseux
- Personal Network
